Scientists Discover New Way That HIV Evades the Immune System
Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a number of biological molecules that are key in blocking viral activity and clearing infection.
HIV remains a major global health problem, with more than 40 million people infected worldwide. And while people living with HIV have been treated with antiretroviral therapy for over 30 years, this favored therapeutic option merely prevents the progression of the disease to AIDS - it doesn't cure patients of HIV.
The discovery, which opens the door to a new era of HIV research focused on curing people living with the virus, has just been published in international journal, EBioMedicine, which is a collaborative online journal from Cell Press and the Lancet.
During any viral infection our immune system produces a powerful molecule (Interferon), which 'interferes' with the infection and the replication of viruses. Interferon activates an assembly line of molecules in our cells -- via the Interferon signalling pathway - which causes the body to make antivirals that help to clear the infection.
However, when patients are being treated with antiretroviral therapy, HIV is not fully cleared by our immune system. Therefore, the scientists from Trinity College Dublin behind the research investigated whether HIV was somehow blocking the Interferon signalling pathway and thus avoiding the immune response that is designed to cure viral infection. The findings confirmed their suspicions.
Nigel Stevenson, assistant professor in immunology at Trinity, led the work. He said, "We discovered that HIV promotes the destruction of the anti-viral Interferon signalling pathway. Essentially, HIV uses the machinery in our own cells to do this, and the virus is thus able to reduce the production of many important anti-viral molecules. Without these antiviral molecules, our immune system can't clear viral infections. Our new revelation sheds new light on how HIV avoids elimination, which, in turn, may explain why HIV is still not a curable disease. We feel this discovery could mark a paradigm shift in our understanding of how this virus evades our immune response. It should open the door to a new era of HIV research aiming to cure and eradicate this deadly virus."
Source: Trinity College Dublin
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
